Vaccine Partner Valneva receives FDA approval for the World's first chikungunya vaccine using Albumedix' Recombumin®

Albumedix, now part of Sartorius Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom India South Korea United States of America Canada Europe Japan

View original content:https://www.prnewswire.co.uk/news-releases/vaccine-partner-valneva-receives-fda-approval-for-the-worlds-first-chikungunya-vaccine-using-albumedix-recombumin-301995668.html